• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

奥密克戎:为何最新的 SARS-CoV-2 变体如此令人担忧?

Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?

机构信息

Institute of Electrochemistry, Ulm University, Ulm, Germany.

Institute of Molecular Virology, Ulm University Medical Center, Ulm, Germany.

出版信息

J Virol. 2022 Mar 23;96(6):e0207721. doi: 10.1128/jvi.02077-21.

DOI:10.1128/jvi.02077-21
PMID:35225672
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8941872/
Abstract

Emerging strains of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the coronavirus disease 2019 (COVID-19) pandemic, that show increased transmission fitness and/or immune evasion are classified as "variants of concern" (VOCs). Recently, a SARS-CoV-2 variant first identified in November 2021 in South Africa has been recognized as a fifth VOC, termed "Omicron." What makes this VOC so alarming is the high number of changes, especially in the viral Spike protein, and accumulating evidence for increased transmission efficiency and escape from neutralizing antibodies. In an amazingly short time, the Omicron VOC has outcompeted the previously dominating Delta VOC. However, it seems that the Omicron VOC is overall less pathogenic than other SARS-CoV-2 VOCs. Here, we provide an overview of the mutations in the Omicron genome and the resulting changes in viral proteins compared to other SARS-CoV-2 strains and discuss their potential functional consequences.

摘要

新型严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)株,即导致 2019 年冠状病毒病(COVID-19)大流行的病原体,其传播适应性和/或免疫逃避能力增强的被归类为“关注变种”(VOCs)。最近,南非于 2021 年 11 月首次发现的一种 SARS-CoV-2 变种被确认为第五种 VOC,称为“奥密克戎”。这种 VOC 如此令人担忧的原因是其病毒刺突蛋白发生了大量变化,并且有越来越多的证据表明其传播效率提高,并能逃避中和抗体。奥密克戎 VOC 在极短的时间内已超过之前占主导地位的德尔塔 VOC。然而,奥密克戎 VOC 的总体致病性似乎低于其他 SARS-CoV-2 VOC。在这里,我们概述了奥密克戎基因组中的突变以及与其他 SARS-CoV-2 株相比病毒蛋白的变化,并讨论了它们潜在的功能后果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/ae2fe12d56f2/jvi.02077-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/10f21f70319e/jvi.02077-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/e191e94c964a/jvi.02077-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/ae2fe12d56f2/jvi.02077-21-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/10f21f70319e/jvi.02077-21-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/e191e94c964a/jvi.02077-21-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/997a/8941872/ae2fe12d56f2/jvi.02077-21-f003.jpg

相似文献

1
Omicron: What Makes the Latest SARS-CoV-2 Variant of Concern So Concerning?奥密克戎:为何最新的 SARS-CoV-2 变体如此令人担忧?
J Virol. 2022 Mar 23;96(6):e0207721. doi: 10.1128/jvi.02077-21.
2
Update on SARS-CoV-2 Omicron Variant of Concern and Its Peculiar Mutational Profile.关于关注的 SARS-CoV-2 奥密克戎变异株及其特殊突变特征的最新信息。
Microbiol Spectr. 2022 Apr 27;10(2):e0273221. doi: 10.1128/spectrum.02732-21. Epub 2022 Mar 30.
3
Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) variant of concern and its global perspective.新型关注变异株 SARS-CoV-2 奥密克戎(B.1.1.529)的特征及其全球视角。
J Med Virol. 2022 Apr;94(4):1738-1744. doi: 10.1002/jmv.27524. Epub 2022 Jan 11.
4
The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.假型 SARS-CoV-2 变异株奥密克戎的显著免疫逃逸。
Emerg Microbes Infect. 2022 Dec;11(1):1-5. doi: 10.1080/22221751.2021.2017757.
5
SARS-CoV-2 strains bearing Omicron BA.1 spike replicate in C57BL/6 mice.携带奥密克戎 BA.1 刺突的 SARS-CoV-2 株在 C57BL/6 小鼠中复制。
Front Immunol. 2024 Apr 29;15:1383612. doi: 10.3389/fimmu.2024.1383612. eCollection 2024.
6
Omicron Genetic and Clinical Peculiarities That May Overturn SARS-CoV-2 Pandemic: A Literature Review.奥密克戎的遗传和临床特征可能颠覆 SARS-CoV-2 大流行:文献综述。
Int J Mol Sci. 2022 Feb 11;23(4):1987. doi: 10.3390/ijms23041987.
7
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern.关注的新冠病毒变异株的生物学功能及临床意义
Front Med (Lausanne). 2022 May 20;9:849217. doi: 10.3389/fmed.2022.849217. eCollection 2022.
8
Characterization of Entry Pathways, Species-Specific Angiotensin-Converting Enzyme 2 Residues Determining Entry, and Antibody Neutralization Evasion of Omicron BA.1, BA.1.1, BA.2, and BA.3 Variants.刺突蛋白结构特征、决定病毒进入宿主细胞的物种特异性血管紧张素转换酶 2 残基,以及奥密克戎 BA.1、BA.1.1、BA.2 和 BA.3 变异株的抗体中和逃逸。
J Virol. 2022 Sep 14;96(17):e0114022. doi: 10.1128/jvi.01140-22. Epub 2022 Aug 24.
9
Sequence analysis of the emerging SARS-CoV-2 variant Omicron in South Africa.南非出现的 SARS-CoV-2 变异株奥密克戎的序列分析。
J Med Virol. 2022 Apr;94(4):1728-1733. doi: 10.1002/jmv.27516. Epub 2021 Dec 27.
10
A Detailed Overview of SARS-CoV-2 Omicron: Its Sub-Variants, Mutations and Pathophysiology, Clinical Characteristics, Immunological Landscape, Immune Escape, and Therapies.关于 SARS-CoV-2 奥密克戎的详细概述:其亚变体、突变和病理生理学、临床特征、免疫状况、免疫逃逸以及治疗方法。
Viruses. 2023 Jan 5;15(1):167. doi: 10.3390/v15010167.

引用本文的文献

1
Temporal dynamics of SARS-CoV-2 phylogenetic diversity in Central Brazil reveals evolutionary shifts among variants of concern during the pandemic.巴西中部地区新冠病毒系统发育多样性的时间动态揭示了疫情期间受关注变异株之间的进化转变。
Front Microbiol. 2025 Aug 13;16:1639187. doi: 10.3389/fmicb.2025.1639187. eCollection 2025.
2
A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron.单个突变可能有助于新冠病毒向奥密克戎毒株加速进化。
Nat Commun. 2025 Jul 29;16(1):6951. doi: 10.1038/s41467-025-62300-0.
3
In Silico Analysis of Post-COVID-19 Condition (PCC) Associated SNP rs9367106 Predicts the Molecular Basis of Abnormalities in the Lungs and Brain Functions.

本文引用的文献

1
Probing the mutational landscape of the SARS-CoV-2 spike protein via quantum mechanical modeling of crystallographic structures.通过晶体结构的量子力学建模探究严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的突变情况。
PNAS Nexus. 2022 Sep 1;1(5):pgac180. doi: 10.1093/pnasnexus/pgac180. eCollection 2022 Nov.
2
The P681H Mutation in the Spike Glycoprotein of the Alpha Variant of SARS-CoV-2 Escapes IFITM Restriction and Is Necessary for Type I Interferon Resistance.阿尔法变异株的刺突糖蛋白中的 P681H 突变逃避了 IFITM 的限制,并且是 I 型干扰素抵抗所必需的。
J Virol. 2022 Dec 14;96(23):e0125022. doi: 10.1128/jvi.01250-22. Epub 2022 Nov 9.
3
新冠后状况(PCC)相关单核苷酸多态性rs9367106的计算机模拟分析预测肺和脑功能异常的分子基础。
Int J Mol Sci. 2025 Jul 11;26(14):6680. doi: 10.3390/ijms26146680.
4
Mutation T9I in Envelope confers autophagy resistance to SARS-CoV-2 Omicron.包膜蛋白中的T9I突变赋予了新冠病毒奥密克戎变异株自噬抗性。
iScience. 2025 Jun 20;28(7):112974. doi: 10.1016/j.isci.2025.112974. eCollection 2025 Jul 18.
5
Synergizing Attribute-Guided Latent Space Exploration (AGLSE) with Classical Molecular Simulations to Design Potent Pep-Magnet Peptide Inhibitors to Abrogate SARS-CoV-2 Host Cell Entry.将属性引导的潜在空间探索(AGLSE)与经典分子模拟相结合,以设计有效的 Pep-Magnet 肽抑制剂来阻断 SARS-CoV-2 进入宿主细胞。
Viruses. 2025 Jun 7;17(6):828. doi: 10.3390/v17060828.
6
SARS-CoV-2 spike protein: structure, viral entry and variants.严重急性呼吸综合征冠状病毒2刺突蛋白:结构、病毒进入及变体
Nat Rev Microbiol. 2025 May 6. doi: 10.1038/s41579-025-01185-8.
7
Design, Synthesis, and Biological Evaluation of 5,8-Dimethyl Shikonin Oximes as SARS-CoV-2 M Inhibitors.5,8-二甲基紫草素肟作为新型冠状病毒M蛋白抑制剂的设计、合成及生物学评价
Molecules. 2025 Mar 14;30(6):1321. doi: 10.3390/molecules30061321.
8
COVID-19 Vaccine Booster Dose Fails to Enhance Antibody Response to Omicron Variant in Reinfected Healthcare Workers.新冠疫苗加强针未能增强再次感染的医护人员对奥密克戎变异株的抗体反应。
Viruses. 2025 Jan 9;17(1):78. doi: 10.3390/v17010078.
9
SARS-CoV-2 transmission dynamics in Mozambique and Zimbabwe during the first 3 years of the pandemic.疫情头三年莫桑比克和津巴布韦的新冠病毒传播动态
R Soc Open Sci. 2025 Jan 22;12(1):241275. doi: 10.1098/rsos.241275. eCollection 2025 Jan.
10
Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2.探索新型冠状病毒(SARS-CoV-2)阿尔法、德尔塔和奥密克戎变异株的复制及致病特征
Int J Mol Sci. 2024 Nov 25;25(23):12641. doi: 10.3390/ijms252312641.
Improved Neutralisation of the SARS-CoV-2 Omicron Variant following a Booster Dose of Pfizer-BioNTech (BNT162b2) COVID-19 Vaccine.
辉瑞-生物科技(BNT162b2) COVID-19 疫苗加强针接种后对 SARS-CoV-2 奥密克戎变异株的中和能力增强。
Viruses. 2022 Sep 13;14(9):2023. doi: 10.3390/v14092023.
4
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.SARS-CoV-2 奥密克戎 BA.5:与关注的病毒变体相比,其对潜在体液反应的趋化性和逃逸能力以及对临床免疫疗法的耐药性不断进化。
EBioMedicine. 2022 Oct;84:104270. doi: 10.1016/j.ebiom.2022.104270. Epub 2022 Sep 18.
5
The roles of APOBEC-mediated RNA editing in SARS-CoV-2 mutations, replication and fitness.APOBEC 介导的 RNA 编辑在 SARS-CoV-2 突变、复制和适应性中的作用。
Sci Rep. 2022 Sep 13;12(1):14972. doi: 10.1038/s41598-022-19067-x.
6
Omicron BA.1 and BA.2 variants increase the interactions of SARS-CoV-2 spike glycoprotein with ACE2.奥密克戎 BA.1 和 BA.2 变异体增加了 SARS-CoV-2 刺突糖蛋白与 ACE2 的相互作用。
J Mol Graph Model. 2022 Dec;117:108286. doi: 10.1016/j.jmgm.2022.108286. Epub 2022 Aug 4.
7
Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.英国与奥密克戎相关的新冠病毒症状变化
Clin Infect Dis. 2022 Aug 3;76(3):e133-41. doi: 10.1093/cid/ciac613.
8
Limited neutralisation of the SARS-CoV-2 Omicron subvariants BA.1 and BA.2 by convalescent and vaccine serum and monoclonal antibodies.恢复期血清和疫苗血清及单克隆抗体对 SARS-CoV-2 奥密克戎亚变种 BA.1 和 BA.2 的中和作用有限。
EBioMedicine. 2022 Aug;82:104158. doi: 10.1016/j.ebiom.2022.104158. Epub 2022 Jul 11.
9
Pathogenicity, transmissibility, and fitness of SARS-CoV-2 Omicron in Syrian hamsters.奥密克戎变异株在叙利亚仓鼠中的致病性、传染性和适应性。
Science. 2022 Jul 22;377(6604):428-433. doi: 10.1126/science.abn8939. Epub 2022 Jun 23.
10
International risk of SARS-CoV-2 Omicron variant importations originating in South Africa.南非起源的 SARS-CoV-2 奥密克戎变异株输入的国际风险。
J Travel Med. 2022 Sep 17;29(6). doi: 10.1093/jtm/taac073.